Larry Jasinski CEO of ReWalk

International study of medical effectiveness of Rewalk systems just released

International study of medical effectiveness of Rewalk systems just released

Determined2Heal recently published the results of an "Evaluation of the ReWalk Computerized Exoskeleton for Patients with Spinal Cord Injury in Community Settings".

Unique 5-year collaboration and extensive IP licensing agreement

Unique 5-year collaboration and extensive IP licensing agreement

ReWalk just announced its agreement with the Wyss Institute at Harvard University for collaboration on the development of "Soft Suit" exoskeleton systems for the treatment of stroke, Multiple Sclerosis and limited mobility patients.